Jean David Bouaziz

Summary

Country: France

Publications

  1. ncbi request reprint IL-10 producing regulatory B cells in mice and humans: state of the art
    J D Bouaziz
    Hopital Saint Louis, INSERM U976, Equerre Bazin, 1 avenue Claude Vellefaux, F 75010, Paris, France
    Curr Mol Med 12:519-27. 2012
  2. doi request reprint IL-10 produced by activated human B cells regulates CD4(+) T-cell activation in vitro
    Jean David Bouaziz
    INSERM U976, Saint Louis Hospital, Skin Research Center, Paris, France
    Eur J Immunol 40:2686-91. 2010
  3. doi request reprint Intravenous immunoglobulins in difficult-to-treat ulcerated livedoid vasculopathy: five cases and a literature review
    Touda Bounfour
    Department of Dermatology, AP HP, Saint Louis Hospital and Paris 7 Diderot Sorbonne University, Paris, France
    Int J Dermatol 52:1135-9. 2013
  4. pmc Active chronic sarcoidosis is characterized by increased transitional blood B cells, increased IL-10-producing regulatory B cells and high BAFF levels
    Anne Saussine
    INSERM U976, Paris, France
    PLoS ONE 7:e43588. 2012

Collaborators

Detail Information

Publications4

  1. ncbi request reprint IL-10 producing regulatory B cells in mice and humans: state of the art
    J D Bouaziz
    Hopital Saint Louis, INSERM U976, Equerre Bazin, 1 avenue Claude Vellefaux, F 75010, Paris, France
    Curr Mol Med 12:519-27. 2012
    ..These recent findings imply that manipulating IL-10 production by human B cells could be a useful therapeutic strategy for modulating immune responses in humans...
  2. doi request reprint IL-10 produced by activated human B cells regulates CD4(+) T-cell activation in vitro
    Jean David Bouaziz
    INSERM U976, Saint Louis Hospital, Skin Research Center, Paris, France
    Eur J Immunol 40:2686-91. 2010
    ..These findings imply that manipulating IL-10 production by human B cells could be a useful therapeutic strategy for modulating immune responses in humans...
  3. doi request reprint Intravenous immunoglobulins in difficult-to-treat ulcerated livedoid vasculopathy: five cases and a literature review
    Touda Bounfour
    Department of Dermatology, AP HP, Saint Louis Hospital and Paris 7 Diderot Sorbonne University, Paris, France
    Int J Dermatol 52:1135-9. 2013
    ..Livedoid vasculopathy (LV) is a thrombotic vasculopathy of the skin of unknown origin. No treatment has been validated in this indication, but case reports suggest the successful use of intravenous immunoglobulins (IVIG) in LV...
  4. pmc Active chronic sarcoidosis is characterized by increased transitional blood B cells, increased IL-10-producing regulatory B cells and high BAFF levels
    Anne Saussine
    INSERM U976, Paris, France
    PLoS ONE 7:e43588. 2012
    ..The purpose of this study is to describe B cell peripheral compartment in sarcoidosis...